Clinical Relevance of CYP2D6 Genetics for Tamoxifen Response in Breast Cancer-Reference-Cited by-同舟云学术

Clinical Relevance of CYP2D6 Genetics for Tamoxifen Response in Breast Cancer

Published:2008 Issue:1 Volume:3 Page:43-50
ISSN:1661-3805
Container-title:Breast Care
language:en
Short-container-title:Breast Care

Author:

Brauch Hiltrud,Schroth Werner,Eichelbaum Michel,Schwab Matthias,Harbeck Nadia

Publisher

S. Karger AG

Subject

Oncology,Surgery

Reference34 articles.

1. AGO: Diagnostic and treatment of patients with primary and metastatic breast cancer: guidelines of AGO Breast Commission, Kommission Mamma-Arbeitsgemeinschaft Gynaekologische Onkologie, 2007.

2. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

3. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007

4. Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

5. Male breast cancer

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-tumoral activity of Allium roseum compounds on breast cancer cells MCF7 and MDA-MB231;Advances in Traditional Medicine;2023-08-22

2. Influence of CYP2D6, CYP2C19 and CYP3A5 polymorphisms on plasma levels of tamoxifen metabolites in Algerian women with ER+ breast cancer;Egyptian Journal of Medical Human Genetics;2022-08-14

3. Integration analysis of metabolome and transcriptome profiles revealed the age-dependent dynamic change in chicken meat;Food Research International;2022-06

4. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma;Frontiers in Oncology;2021-09-09

5. Moving Pharmacogenetics Into Practice: It’s All About the Evidence!;Clinical Pharmacology & Therapeutics;2021-07-07